Westbrook, Jules AWood, Steven LCairns, David AMcMahon, KathrynGahlaut, RenuThygesen, HeleneShires, MikeRoberts, StephanieMarshall, HelenOliva, Maria RDunning, Mark JHanby, Andrew MSelby, Peter JSpeirs, ValerieMavria, GeorgiaColeman, Robert E.Brown, Janet E2019-11-142019-11-142019-03-01Westbrook, J A, Wood, S L, Cairns, D A, McMahon, K, Gahlaut, R, Thygesen, H, Shires, M, Roberts, S, Marshall, H, Oliva, M R, Dunning, M J, Hanby, A M, Selby, P J, Speirs, V, Mavria, G, Coleman, R E & Brown, J E 2019, 'Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer', The Journal of pathology, vol. 247, no. 3, pp. 381-391. https://doi.org/10.1002/path.51970022-3417Mendeley: 7de19d79-d3d9-3c4a-af1e-378cc8745e53ORCID: /0000-0002-0602-4666/work/72631335https://hdl.handle.net/2164/13265Funding Information Cancer Research UK. Grant Number: C18605/A 10048 Yorkshire Cancer Research. Grant Number: S315 Breast Cancer Now. Grant Numbers: 2012MaySP047, 2016MayPR74 UK Medical Research Council. Grant Number: G08024161121671792102073engSDG 3 - Good Health and Well-beingDOCK4bone metastasisbreast cancerbiomarkerproteomicsRB PathologyPathology and Forensic MedicineMedical Research Council (MRC)G0802416Cancer Research UKC18605/A 10048Supplementary DataRBJournal article10.1002/path.5197http://www.scopus.com/inward/record.url?scp=85060606747&partnerID=8YFLogxKhttp://www.mendeley.com/research/identification-validation-dock4-potential-biomarker-risk-bone-metastasis-development-patients-early